MedPath

Evaluation of Safety and Tolerability of Investigational Ocular Lubricants

Not Applicable
Completed
Conditions
Dry Eye Disease
Registration Number
NCT05888519
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to evaluate investigational ocular lubricants for their safety and tolerability on subjects with mild to moderate dry eye disease.

Detailed Description

Subjects will be expected to attend a screening visit followed by 6 additional study visits. The expected duration of subject participation is approximately 3 weeks. This study will be conducted in Australia.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
47
Inclusion Criteria
  • Sign an Informed Consent;
  • Have dry eye symptoms;
  • Other protocol-specified inclusion criteria may apply.

Key

Exclusion Criteria
  • Ocular abnormalities;
  • Active ocular infection or inflammation not associated with dry eye;
  • History of ocular or intraocular surgery;
  • Other protocol-defined exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Best corrected visual acuity (BCVA) with manifest refraction, at distanceDay 1, each wear period. A wear period is 1 day.

BCVA will be collected for each eye individually and recorded in logarithm Minimum Angle of Resolution (logMAR)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

George Street Eye Centre

🇦🇺

Sydney, New South Wales, Australia

Ophthalmic Trials Australia

🇦🇺

Teneriffe, Queensland, Australia

University of Melbourne, Department of Optometry and Vision Science

🇦🇺

Carlton, Victoria, Australia

George Street Eye Centre
🇦🇺Sydney, New South Wales, Australia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.